Literature DB >> 21538232

Peripartum angiopathy with simultaneous sinus venous thrombosis, cervical artery dissection and cerebral arterial vasoconstriction.

Markus Hoeren, Claudia Hader, Sandra Strümpell, Cornelius Weiller, Matthias Reinhard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21538232     DOI: 10.1007/s00415-011-6047-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  15 in total

1.  Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis.

Authors:  D J Lanska; R J Kryscio
Journal:  Stroke       Date:  2000-06       Impact factor: 7.914

2.  Dural puncture headache, postpartum angiopathy, pre-eclampsia and cortical vein thrombosis after an uncomplicated pregnancy.

Authors:  L W Katzin; M Levine; A B Singhal
Journal:  Cephalalgia       Date:  2007-03-14       Impact factor: 6.292

Review 3.  Narrative review: reversible cerebral vasoconstriction syndromes.

Authors:  Leonard H Calabrese; David W Dodick; Todd J Schwedt; Aneesh B Singhal
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

4.  Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes.

Authors:  Shih-Pin Chen; Jong-Ling Fuh; Shuu-Jiun Wang; Feng-Chi Chang; Jiing-Feng Lirng; Ying-Chen Fang; Ben-Chang Shia; Jaw-Ching Wu
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

5.  Reversible cerebral vasoconstriction syndrome with posterior leucoencephalopathy after oral contraceptive pills.

Authors:  Y Soo; A B Singhal; T Leung; S Yu; H Mak; Q Hao; H Leung; W Lam; L K S Wong
Journal:  Cephalalgia       Date:  2010-01       Impact factor: 6.292

6.  Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers.

Authors:  Hirofumi Yasue; Yuji Mizuno; Eisaku Harada; Teruhiko Itoh; Hitoshi Nakagawa; Masafumi Nakayama; Hisao Ogawa; Shinji Tayama; Takasi Honda; Seiji Hokimoto; Shuichi Ohshima; Youichi Hokamura; Kiyotaka Kugiyama; Minoru Horie; Michihiro Yoshimura; Masaki Harada; Shiroh Uemura; Yoshihiko Saito
Journal:  J Am Coll Cardiol       Date:  2008-05-06       Impact factor: 24.094

7.  Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients.

Authors:  P Lüdemann; D G Nabavi; R Junker; E Wolff; K Papke; H Buchner; G Assmann; E B Ringelstein
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

8.  The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients.

Authors:  Anne Ducros; Monique Boukobza; Raphaël Porcher; Mariana Sarov; Dominique Valade; Marie-Germaine Bousser
Journal:  Brain       Date:  2007-11-19       Impact factor: 13.501

9.  Postpartum cervicocephalic artery dissection.

Authors:  Marcel Arnold; Mathilde Camus-Jacqmin; Christian Stapf; Anne Ducros; Anand Viswanathan; Karine Berthet; Marie Germaine Bousser
Journal:  Stroke       Date:  2008-06-05       Impact factor: 7.914

10.  Transcranial color doppler study for reversible cerebral vasoconstriction syndromes.

Authors:  Shih-Pin Chen; Jong-Ling Fuh; Feng-Chi Chang; Jiing-Feng Lirng; Ben-Chang Shia; Shuu-Jiun Wang
Journal:  Ann Neurol       Date:  2008-06       Impact factor: 10.422

View more
  3 in total

Review 1.  The etiologies of new cases of cerebral venous sinus thrombosis reported in the past year.

Authors:  Ran Meng; Xunming Ji; Xiaoying Wang; Yuchuan Ding
Journal:  Intractable Rare Dis Res       Date:  2012-02

Review 2.  Neurological Complications of Pregnancy.

Authors:  H Steven Block
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

3.  Reversible cerebral vasoconstriction syndrome concomitant with cerebral venous sinus thrombosis following ovarian tumor resection: A report of two cases.

Authors:  Yu Shimizu; Katsuhiro Tsuchiya; Hironori Fujisawa
Journal:  Surg Neurol Int       Date:  2020-05-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.